Skip to main content
. 2019 Jun 11;36(7):1457–1469. doi: 10.1007/s10815-019-01489-8

Table 1.

Patient demographics and cycle information

Pt# Age BMI Diagnosis/PGT-A reason Cycle # Day 3 FSH level (IU/ml) E2 per oocyte (pg/ml) # oocytes # mature # fertilized # embryos biopsied Trigger
1 27.8 25.3 Sex selection 3 5.4 141.9 8 8 8 4 hCG
2 36.4 26.4 Male factor 1 7.2 86.6 8 7 6 4 hCG
3 39.7 25 AMA 1 12 100.4 7 4 3 3 hCG
4 30 25.6 Donor 1 6 147.4 10 9 7 6 hCG
5 32.6 26.4 Translocation w/PGT-A 2 9.2 131.0 5 5 5 5 Lupron
6 35.9 21 Idiopathic 1 8.3 163.3 4 4 4 2 Lupron
7 39.7 38.8 AMA 1 11 145.5 9 9 6 5 Lupron
8 40 32 AMA + male factor 1 12 31.4 7 5 5 4 Lupron
9 33 18.8 Male factor 1 10 194.7 11 10 10 4 Lupron
10 42 20.3 AMA 1 6.6 108.2 5 5 5 3 hCG
11 36.1 29.2 Tubal factor 1 5.2 179.5 23 23 18 12 Lupron
12 37 20.7 AMA 1 11 142.2 16 15 14 8 Lupron
13 33.9 35 Male factor 2 10 183.1 11 10 8 2 hCG
14 28 28.4 PCO 1 5.9 184.2 24 6 5 4 hCG
15 39.7 31 AMA 1 7.5 132.6 16 14 14 7 Lupron

AMA advanced maternal age, PCO polycystic ovaries, hCG human chorionic gonadotropin